Qiuyu Li
Luzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Canagliflozin regulates adipocyte lipolysis in vitro via a SGLT2 independent signaling pathway.
Journal: International journal of obesity (2005)
Published: March 25, 2025
DIA-based quantitative proteomics explores the mechanism of amelioration of APAP-induced liver injury by anoectochilus roxburghii (Wall.) Lindl.
Journal: Frontiers in pharmacology
Published: October 30, 2024
The clinical features and risk factors of coagulopathy associated with cefoperazone/sulbactam: a nomogram prediction model.
Journal: Frontiers in pharmacology
Published: October 03, 2024
The diabetes medication Canagliflozin attenuates alcoholic liver disease by reducing hepatic lipid accumulation via SIRT1-AMPK-mTORC1 signaling pathway.
Journal: European journal of pharmacology
Published: September 30, 2024
Autophagy and PPARs/NF-κB-associated inflammation are involved in hepatotoxicity induced by the synthetic phenolic antioxidant 2,4-di-tert-butylphenol in common carp (Cyprinus carpio).
Journal: Ecotoxicology and environmental safety
Published: June 16, 2024
Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events.
Journal: Frontiers in pharmacology
Published: April 13, 2024
Antagonizing effects of curcumin against mercury-induced autophagic death and trace elements disorder by regulating PI3K/AKT and Nrf2 pathway in the spleen.
Journal: Ecotoxicology and environmental safety
Published: March 31, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026